Galunisertib

galunisertib · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Galunisertib, covering 2016-02-10 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer [Phase 2]